John Sperzel

John Sperzel

No open positions remaining

Net worth: - $ as of 31/05/2026

62 year
Health Technology
Consumer Services

Profile

John J.
Sperzel
formerly worked at Chembio Diagnostics, Inc., as President, Chief Executive Officer & Director from 2014 to 2017, Chembio Diagnostics, Inc., as President, CEO & Independent Director from 2014 to 2020, ITC Nexus Holding Co., Inc., as Chief Executive Officer from 2011 to 2013, Chembio Diagnostic Systems, Inc., as President, Chief Executive Officer & Director, International Technidyne Corp., as President & Chief Executive Officer from 2011 to 2013, T2 Biosystems, Inc., as Chairman, President & Chief Executive Officer from 2021 to 2025, Diadexus, Inc., as Director, Ontera, Inc., as Director, Bayer Diagnostics Corp., as President-Marketing & Business Development from 2000 to 2009, Axis-Shield Ltd., as President-USA, and Roche Diagnostics Corp., as Vice President from 1987 to 1997.
Mr. Sperzel received his undergraduate degree from Plymouth State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
07/01/2025 400 ( 0% ) 0 $ 31/05/2026

Former positions of John Sperzel

CompaniesPositionEnd
T2 BIOSYSTEMS, INC. Chief Executive Officer 31/03/2025
CHEMBIO DIAGNOSTICS, INC. Chief Executive Officer 09/01/2020
CHEMBIO DIAGNOSTICS, INC. Chief Executive Officer 30/05/2017
Chief Executive Officer 01/12/2013
Chief Executive Officer 01/12/2013
See the detail of John Sperzel's experience

Training of John Sperzel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

43

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology